CVLB - Conversion Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1300
-0.0200 (-13.33%)
At close: 11:24AM EDT
Stock chart is not supported by your current browser
Previous Close0.1500
Open0.1478
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1300 - 0.1500
52 Week Range0.0800 - 0.3400
Volume31,156
Avg. Volume20,336
Market Cap6.095M
Beta (3Y Monthly)1.32
PE Ratio (TTM)N/A
EPS (TTM)-0.0560
Earnings DateMar 7, 2019 - Mar 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswirelast month

    Conversion Labs Strengthens Board of Directors with Appointment of Two New Directors

    Conversion Labs, Inc. (CVLB) (the “Company” or “Conversion Labs”), an e-commerce company that builds proprietary consumer products and software brands, today announced that it has appointed Happy Walters and Bertrand Velge to its Board of Directors (the “Board”) effective June 11, 2019. In addition, the Company’s President, CEO and largest shareholder, Justin Schreiber will assume the role of Chairman of the Board.

  • GlobeNewswire2 months ago

    Conversion Labs Announces Telemedicine Joint Venture and Strategic Partnership with GoGoMeds

    Conversion Labs, Inc. (CVLB) (the “Company” or “Conversion Labs”), an e-commerce company focused on creating, acquiring and scaling proprietary consumer products and software, today announced that it has entered into a telemedicine joint venture and strategic partnership agreement with GoGoMeds.com. GoGoMeds is one of the largest and fastest growing online pharmacies in the United States, licensed to dispense and ship prescription drugs to patients in all 50 states and the District of Columbia. In 2016, the top 20 leading drug store chains in the US captured $225.30 billion in prescription drug sales.

  • GlobeNewswire3 months ago

    Conversion Labs Announces PDF Simpli Achieves Milestone of Over 1 Million Registered Users

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today announced that the Company’s majority owned subsidiary, LegalSimpli Software LLC, achieved a milestone of over 1 million registered users of its PDF Simpli software product.

  • GlobeNewswire3 months ago

    Conversion Labs to Host Conference Call This Afternoon to Discuss FY 2018 and 2019 Expectations

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, will be hosting a conference call today to discuss the results of Fiscal Year 2018, preliminary figures for First Quarter 2019, and plans for the remainder of Fiscal Year 2019. Conversion Labs reported record yearly revenues of $8.324M for the 2018 Fiscal Year, where the company divested its legacy manufacturing business and expanded its e-commerce portfolio. In preliminary results for 2019, the Company estimates record gross revenue of approximately $3.03 million for Q1 2019, in which March is estimated to have generated $1.32 million.

  • GlobeNewswire3 months ago

    Conversion Labs Announces Record Monthly and Quarterly Sales; Results To Be Discussed In Upcoming Conference Call

    The Company will be hosting a conference call this week to discuss these results and provide additional detail on the Company’s plan for growth in 2019. Conversion Labs’ portfolio of brands experienced strong sales growth in the first quarter of fiscal year 2019. Driven primarily by sales of Shapiro MD, the Company estimates record gross revenue of approximately $3.03 million for Q1 2019.  March 2019 was the strongest month in the history of the Company with combined gross revenues of LegalSimpli Software and Conversion Labs PR totaling approximately $1.32 million.

  • GlobeNewswire4 months ago

    Conversion Labs to Host Conference Call on April 10 2019 to Discuss Fiscal Year 2018 Results

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, will be hosting a conference call to discuss its corporate and financial results for the Fiscal Year ended 2018 and plans for upcoming fiscal year 2019. "2018 was a year in which we diversified operations and made big investments in infrastructure and human capital that we believe will provide a foundation for strong future growth,” stated Justin Schreiber, President and CEO of Conversion Labs.

  • GlobeNewswire4 months ago

    Conversion Labs Announces Robust Sales Traction To Start 2019

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products and software, today announced promising sales data to start 2019, driven by sales of the Company’s two main products Shapiro MD and iNR Wellness MD as well as recently launched Scarology. Conversion Labs’ portfolio of products experienced strong demand to start fiscal year 2019.

  • GlobeNewswire8 months ago

    Conversion Labs’ Recognized In Deloitte’s “Technology Fast 500” Ranking

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products and software, today announced that the Company was included in Deloitte’s Technology Fast 500™, ranked as the 164th fastest growing technology company in North America. Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences, and energy tech companies in North America.

  • GlobeNewswire8 months ago

    Conversion Labs Reports Record-Breaking Quarterly Results

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products and software, today reported financial results for the third quarter of 2018 and nine months ended September 30, 2018. For the quarter ended September 30, 2018, revenues grew to $2.50 Million or 22%, compared to the same period one year ago, reflecting the Company's focus on growing its Shapiro MD product line and launch of its new software-as-a-service (SaaS) product PDF Simpli. Gross profits for the quarter rose 36% to $2.06 Million compared to 1.52 Million in 2017, as a result of product mix and the Company’s efforts to lower costs.